4.7 Article

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

Journal

BLOOD
Volume 122, Issue 5, Pages 749-758

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2013-01-480129

Keywords

-

Categories

Funding

  1. Amber Phillpott Trust
  2. Anya Sturdy Trust
  3. Wellcome Trust
  4. Cancer Research UK [C399/A2291]
  5. UK Medical Research Council
  6. MRC [G1000729, MC_UU_12010/1, MC_UU_12009/11, MC_U137961146] Funding Source: UKRI
  7. Cancer Research UK [11331] Funding Source: researchfish
  8. Medical Research Council [G1000729, MC_UU_12010/1, MC_UU_12009/11, MC_U137961146, G1000801c] Funding Source: researchfish

Ask authors/readers for more resources

Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the second most common frequent leukemia of childhood. Patients may present with lymphopenia or pancytopenia at diagnosis. We investigated the mechanisms by which AML causes pancytopenia and suppresses patients' immune response. This study identified for the first time that AML blasts alter the immune microenvironment through enhanced arginine metabolism. Arginase II is expressed and released from AML blasts and is present at high concentrations in the plasma of patients with AML, resulting in suppression of T-cell proliferation. We extended these results by demonstrating an arginase-dependent ability of AML blasts to polarize surrounding monocytes into a suppressive M2-like phenotype in vitro and in engrafted nonobese diabetic-severe combined immunodeficiency mice. In addition, AML blasts can suppress the proliferation and differentiation of murine granulocyte-monocyte progenitors and human CD34(+) progenitors. Finally, the study showed that the immunosuppressive activity of AML blasts can be modulated through small-molecule inhibitors of arginase and inducible nitric oxide synthase, suggesting a novel therapeutic target in AML. The results strongly support the hypothesis that AML creates an immunosuppressive microenvironment that contributes to the pancytopenia observed at diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available